TAKE vs VIMTALABS: Stock Comparison

TAKE vs VIMTA LABSUpdated 22 Sept 26, 4:08 PM ISTNSE & company filings

VIMTA LABS is the larger company by market capitalisation. TAKE shows lower leverage, while VIMTA LABS shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

TAKE leads 3; VIMTALABS leads 10 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

TAKEVIMTALABS

Valuation lens

What price are you paying?

Market CapContext only
₹234 Cr
₹2,737 Cr
P/E RatioVIMTALABS has the lower reading
26.86x
0x
P/B RatioVIMTALABS has the lower reading
11.13x
0x
EPSVIMTALABS has the higher reading
₹0.07
₹4.71
Book ValueContext only
₹2.1
₹102.28
Dividend YieldVIMTALABS has the higher reading
0%
0.33%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIMTALABS is the larger company
₹2,737 Cr vs ₹234 Cr
P/E Ratio
VIMTALABS has a lower P/E
0x vs 26.86x
P/B Ratio
VIMTALABS has a lower P/B
0x vs 11.13x
EPS
VIMTALABS has higher earnings per share
₹4.71 vs ₹0.07
Dividend Yield
VIMTALABS has a higher dividend yield
0.33% vs 0%
Revenue Growth (TTM YoY)
VIMTALABS has faster revenue growth
16.5% vs 0%
EPS Growth (TTM YoY)
VIMTALABS has faster EPS growth
14.3% vs 0%
Qtr Sales Growth
TAKE has stronger quarterly sales growth
153.77% vs -73.22%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricTAKEVIMTALABS
SectorHealthcare
IndustryHealthcare Research Analytics & Technology

Price

MetricTAKEVIMTALABS
Live Price₹15.84₹610.15
Day Change-3.83%-0.96%
Volume2.55 L1.54 L
52-Week High₹24.39₹828.35
52-Week Low₹10.11₹376.05
Distance from 52W High-35.06%-26.34%

Valuation

MetricTAKEVIMTALABS
Market Cap₹234 Cr₹2,737 Cr
P/E Ratio26.86x0x
P/B Ratio11.13x0x
EPS₹0.07₹4.71
Book Value₹2.1₹102.28
Dividend Yield0%0.33%

Growth

MetricTAKEVIMTALABS
Revenue Growth (TTM YoY)0%16.5%
EPS Growth (TTM YoY)0%14.3%
Qtr Sales Growth153.77%-73.22%
Qtr Profit Growth9.73%-72.85%

Profitability & Leverage

MetricTAKEVIMTALABS
ROE12.68%16.97%
ROCE14.44%17.48%
Net Margin0%19.03%
Operating Margin8.19%25.81%
Debt to Equity0x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricTAKEVIMTALABS
Promoter Holding0%35.67% 0.18 pp
FII Holding0.21% 0.08 pp4.42% 0.47 pp
DII Holding0%0.37% 0.23 pp
Public Holding99.79% 0.08 pp59.55% 0.43 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TAKE and VIMTA LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.